Sagent to issue IPO
SCHAUMBURG, Ill. — Sagent Pharmaceuticals has increased the number of shares it’s issuing in its initial public offering on the Nasdaq, the drug maker said Wednesday.
Originally planning to offer 5 million shares, the company has increased that number to 5.75 million shares at $16 per share.
The underwriters have a 30-day option to purchase up to an additional 862,500 shares at the IPO price. The offering is expected to close next Tuesday.